Jacobio Pharmaceuticals Group Co (HKSE:01167) Short-Term Debt & Capital Lease Obligation : HK$70.4 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Jacobio Pharmaceuticals Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$70.4 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Jacobio Pharmaceuticals Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$92.0 Mil.

Jacobio Pharmaceuticals Group Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Short-Term Debt & Capital Lease Obligation Chart

Jacobio Pharmaceuticals Group Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

10.24

6.02

14.66

96.19

70.42

Jacobio Pharmaceuticals Group Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial								14.66	81.68	96.19	84.52	70.42

Jacobio Pharmaceuticals Group Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Jacobio Pharmaceuticals Group Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

77V:Germany

Address

No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN

Website

https://www.jacobiopharma.com

Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Executives

Yakovpharma Ltd	2501 Other
Blesspharma Ltd	2501 Other
Honourpharma Ltd	2501 Other
Gloryviewpharma Ltd	2501 Other
Hmed Ltd	2501 Other
Johwpharma Ltd	2501 Other
Risepharma Ltd	2101 Beneficial owner
Willgenpharma Ltd	2501 Other
Hu Yunyan	2501 Other
Wang Xiaojie	2307 Founder of a discretionary trust who can infl
Wang Yinxiang	2501 Other
Qiming Corporate Gp Vi, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp Vi, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners Vi, L.p.	2101 Beneficial owner
Hillhouse Investment Management, Ltd.	2102 Investment manager

Jacobio Pharmaceuticals Group Co Headlines

No Headlines